| Literature DB >> 35693954 |
Min Guo1, Boxing Shen1, Jinhong Li1, Xiaoqi Huang1, Jie Hu1, Xiaocheng Wei2, Shaoyu Wang3, Ruohan Yuan1, Chengcheng He1, Yanjing Li1.
Abstract
Background: Patients with temporal lobe epilepsy (TLE) frequently complain of poor sleep quality, which is a condition that clinicians are typically neglecting. In this study, Epworth Sleepiness Scale (ESS), Pittsburgh Sleep Quality Index (PSQI), and Athens Insomnia Scale (AIS) were used to assess the sleep status of patients with temporal lobe epilepsy (TLE). Simultaneously diffusion kurtosis imaging (DKI) was applied to examine the white matter microstructure abnormalities in patients with TLE and sleep disorders.Entities:
Keywords: abnormal white matter structure; diffusional kurtosis imaging (DKI); sleep disorders; sleep questionnaires; temporal lobe epilepsy (TLE)
Year: 2022 PMID: 35693954 PMCID: PMC9177985 DOI: 10.3389/fpsyt.2022.885477
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 5.435
Figure 1A flow chart is used to show the implementation method of the study.
Figure 2Typical diffusional kurtosis imaging (DKI)-derived parametric maps in a case brain. (A) Female, 27 years old, R-TLE with sleep disorder, (B) Male, 35 years old, R-TLE without sleep disorder; from left to right are T2WI images, mean kurtosis (MK) maps, mean diffusivity (MD) maps and fractional anisotropy (FA) maps. No clear abnormalities were seen on T2WI images and DKI images in both patients, which could be detected by measurement of DKI parameters. Note: the unit of MD is μm2/ms, and FA, MK are dimensionless.
The demographic and clinical characteristics in subjects of the study.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| Age (years) | 23.52 ± 11.10 | 27.45 ± 8.51 | 28.52 ± 11.53 | 1.29 | 0.28a |
| Duration (years) | 3 (0.42,8) | 1.2 (1.0,6.7) | / | −1.30 | 0.19b |
| Gender (male/female) | 16/18 | 7/10 | 11/19 | 0.71 | 0.70c |
| Sleep disorder (with/not) | 19/15 | 11/6 | 0/30 | 28.41 | 0.00c |
|
| |||||
| Levetiracetam | 17 | 6 | / | 1.37 | 0.71c |
| Lamotrigine | 6 | 5 | / | ||
| Valproate sodium | 8 | 4 | / | ||
| No medication | 3 | 2 | / |
L-TLE, Left-TLE; R-TLE, Right-TLE; HC, The healthy control group.
.
The score of self-evaluation sleep questionnaire in subjects of the study.
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|
|
|
|
| ||||
| L-TLE ( | 6.21 ± 2.66 | 5.84 ± 2.58 | 5.16 ± 2.60 | 10 | 2 | 5 |
| R-TLE ( | 5.81 ± 2.35 | 6.27 ± 2.53 | 4.46 ± 1.97 | 6 | 1 | 3 |
| HC ( | 2.38 ± 1.28 | 3.15 ± 1.31 | 3.34 ± 1.77 | 0 | 0 | 0 |
| 18.79 | 3.62 | 3.96 | 0.25 | |||
| 0.00a | 0.00a | 0.03a | 1.00b | |||
aAnalysis of variance (ANOVA) .
Figure 3Post-hoc multiple comparison in sleep scores of TLE with sleep disorders and the healthy controls.
ANOVA of DKI parameters between L-TLE with or without sleep disorders and the healthy controls.
|
| |||
|---|---|---|---|
|
|
|
| |
| With sleep disorder ( | 0.8112 ± 0.12 | 1.0550 ± 0.16 | 0.2401 ± 0.08 |
| Without sleep disorder ( | 0.9374 ± 0.13 | 1.0011 ± 0.16 | 0.3041 ± 0.11 |
| HC-L ( | 1.0299 ± 0.15 | 0.9049 ± 0.13 | 0.3655 ± 0.08 |
|
| 15.61 | 6.33 | 13.32 |
| 0.00 | 0.00 | 0.00 | |
Figure 4Post-hoc multiple comparison in DKI parameters of L-TLE with or without sleep disorders and the healthy controls.
ANOVA of DKI parameters between R-TLE with or without sleep disorders and the healthy controls.
|
| |||
|---|---|---|---|
|
|
|
| |
| With sleep disorder ( | 0.7924 ± 0.12 | 1.2568 ± 0.11 | 0.2494 ± 0.06 |
| Without sleep disorder ( | 1.0401 ± 1.13 | 0.9459 ± 0.21 | 0.2863 ± 0.04 |
| HC-R ( | 1.1312 ± 0.15 | 0.8280 ± 0.13 | 0.3701 ± 0.09 |
|
| 22.35 | 39.24 | 9.81 |
| 0.00 | 0.00 | 0.00 | |
Figure 5Post-hoc multiple comparison in DKI parameters of R-TLE with or without sleep disorders and the healthy controls.